Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Oct 24, 2013 · 10-K · 85 days after period end · 0001193125-13-409928
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | $189.00K | $127.00K | $245.00K |
| Net Income | -$2.16M | -$2.51M | -$2.03M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Jul 31, 2013 · filed Oct 24, 2013 · 85 d after period end
